Rutherford Crossing Dialysis in Winchester, Virginia - Dialysis Center

Rutherford Crossing Dialysis is a medicare approved dialysis facility center in Winchester, Virginia and it has 13 dialysis stations. It is located in Frederick county at 141 Market Street, Winchester, VA, 22603. You can reach out to the office of Rutherford Crossing Dialysis at (540) 665-5169. This dialysis clinic is managed and/or owned by Davita. Rutherford Crossing Dialysis has the following ownership type - Profit. It was first certified by medicare in January, 2017. The medicare id for this facility is 492704 and it accepts patients under medicare ESRD program.

Name	Rutherford Crossing Dialysis
Location	141 Market Street, Winchester, Virginia
No. of Dialysis Stations	13
Medicare ID	492704
Managed By	Davita
Ownership Type	Profit
Late Shifts	No

Dialysis Facilities may have multiple NPI numbers. We have found possible NPI number/s associated with Rutherford Crossing Dialysis from NPPES records by matching pattern on the basis of name, address, phone number etc. Please use this information accordingly.

NPI Number	1881047637
Organization Name	Rutherford Crossing Dialysis
Doing Business As	Total Renal Care, Inc.
Address	141 Market St Winchester, Virginia, 22603
Phone Number	(540) 665-5169

Dialysis patients with Hemoglobin data

10

Adult patinets who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be atleast 1.7, that means they are receiving right amount of dialysis. Pediatric patients who undergo hemodialysis, their Kt/V should be atleast 1.2 and for peritoneal dialysis the Kt/V should be 1.8.
Higher percentages should be better.

• Hemodialysis

  Adult patients getting regular hemodialysis at the center	22
  Adult patient months included in Kt/V greater than or equal to 1.2	104
  Percentage of adult patients getting regular hemodialysis at the center	94
  Percentage of pediatric patients getting regular hemodialysis at the center

An important goal of dialysis is to maintain normal levels of various minerals in the body, such as calcium. This shows the percentage of patients treated at Rutherford Crossing Dialysis with elevated calcium levels.

Patients with hypercalcemia	23
Hypercalcemia patient months	108
Patients with Serumphosphor	28
Patients with Serumphosphor less than 3.5 mg/dL	9
Patients with Serumphosphor from 3.5 to 4.5 mg/dL	27
Patients with Serumphosphor from 4.6 to 5.5 mg/dL	41
Patients with Serumphosphor from 5.6 to 7 mg/dL	13
Patients with Serumphosphor greater than 7 mg/dL	10

The arteriovenous (AV) fistulae is considered long term vascular access for hemodialysis because it allows good blood flow, lasts a long time, and is less likely to get infected or cause blood clots than other types of access. Patients who don't have time to get a permanent vascular access before they start hemodialysis treatments may need to use a venous catheter as a temporary access.

Patients included in arterial venous fistula and catheter summaries	27
Patient months included in arterial venous fistula and catheter summaries	118
Percentage of patients getting regular hemodialysis at the center that used an arteriovenous (AV) fistulae for their treatment	81
Percentage of patients receiving treatment through Vascular Catheter for 90 days/longer	7